| |
| |
|
| Insider
Information: |
Schuler Jack W |
| Relationship: |
|
| City: |
Lake Forest |
| State: |
IL |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
13 |
|
| Direct
Shares |
27,956,178 |
|
|
Indirect Shares
|
61,134,751 |
|
|
| Direct
Value |
$198,559,401 |
|
|
|
Indirect Value
|
$175,231,488 |
|
|
| Total
Shares |
89,090,929 |
|
|
| Total
Value |
$373,790,889 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
54
|
96
|
|
Stock
price went up :
|
14
|
2
|
| Stock
price went down : |
40
|
94
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
 -25.7%
|
-5,816.9%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Stericycle Inc |
SRCL |
Director |
2018-03-01 |
626,142 |
2018-03-01 |
56,460 |
Premium* |
|
|
Ventana Medical Systems Inc |
VMSI |
Director |
2008-02-08 |
0 |
2008-02-11 |
0 |
Premium* |
|
|
QuidelOrtho Corporation |
QDEL |
Director, 10% Owner |
2020-05-14 |
3,103,249 |
2018-01-22 |
3,414,053 |
Premium* |
|
|
Oncternal Therapeutics Inc |
ONCT |
10% Owner |
2014-03-21 |
6,165,261 |
2010-12-14 |
21,500 |
Premium* |
|
|
Transition Therapeutics |
TTHI |
10% Owner |
2011-11-22 |
2,823,010 |
2011-11-22 |
0 |
Premium* |
|
|
Yield10 Bioscience Inc |
YTEN |
|
2015-06-19 |
2,185,652 |
2023-12-20 |
63,789 |
Premium* |
|
|
Accelr8 Technology Corp |
AXDX |
Director, 10% Owner |
2024-05-29 |
15,488 |
2024-05-29 |
8,515,885 |
Premium* |
|
|
Aspira Womens Health Inc |
AWH |
|
2017-08-31 |
6,673,029 |
2023-07-24 |
1,883,656 |
Premium* |
|
|
Hansen Medical Inc |
HNSN |
Director |
2014-02-26 |
5,319,769 |
2014-02-26 |
13,249,640 |
Premium* |
|
|
Biolase Inc |
BIOL |
|
|
0 |
2020-02-11 |
759,820 |
Premium* |
|
|
Neos Therapeutics, Inc. |
NEOS |
10% Owner |
2015-07-28 |
1,044,578 |
2017-02-17 |
2,338,671 |
Premium* |
|
|
Soleno Therapeutics Inc |
SLNO |
|
2018-12-21 |
0 |
2022-12-09 |
36,595 |
Premium* |
|
|
Biodesix Inc |
BDSX |
|
2020-10-30 |
0 |
2024-05-23 |
30,794,682 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
634 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 14 of 26
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| AXDX |
Accelr8 Technology Corp |
Director |
– • • |
2016-05-13 |
4 |
B |
$12.45 |
$249,000 |
I/I |
20,000 |
12,045,377 |
2.25 |
- |
|
| AXDX |
Accelr8 Technology Corp |
Director |
– • • |
2017-11-13 |
4 |
B |
$18.98 |
$379,600 |
I/I |
20,000 |
1,464,823 |
2.25 |
- |
|
| AXDX |
Accelr8 Technology Corp |
Director |
– • • |
2018-02-20 |
4 |
B |
$24.95 |
$499,000 |
I/I |
20,000 |
13,145,028 |
2.25 |
- |
|
| AXDX |
Accelr8 Technology Corp |
Director |
– • • |
2018-11-14 |
4 |
A |
$14.24 |
$284,800 |
I/I |
20,000 |
1,650,423 |
0 |
- |
|
| AXDX |
Accelr8 Technology Corp |
Director |
– • • |
2018-12-19 |
4 |
A |
$11.21 |
$224,200 |
I/I |
20,000 |
1,884,423 |
0 |
- |
|
| AXDX |
Accelr8 Technology Corp |
Director |
– • • |
2018-12-20 |
4 |
A |
$10.88 |
$217,600 |
I/I |
20,000 |
1,904,423 |
0 |
- |
|
| AXDX |
Accelr8 Technology Corp |
Director |
– • • |
2018-12-21 |
4 |
A |
$10.44 |
$208,800 |
I/I |
20,000 |
1,924,423 |
0 |
- |
|
| AXDX |
Accelr8 Technology Corp |
Director |
– • • |
2018-12-24 |
4 |
A |
$10.53 |
$210,600 |
I/I |
20,000 |
1,944,423 |
0 |
- |
|
| AXDX |
Accelr8 Technology Corp |
Director |
– • • |
2019-01-08 |
4 |
A |
$14.57 |
$291,400 |
I/I |
20,000 |
1,964,423 |
0 |
- |
|
| AXDX |
Accelr8 Technology Corp |
Director |
– • • |
2020-05-11 |
4 |
B |
$9.99 |
$199,800 |
I/I |
20,000 |
14,754,942 |
2.25 |
% |
|
| AXDX |
Accelr8 Technology Corp |
Director |
– • • |
2020-05-12 |
4 |
B |
$9.92 |
$198,400 |
I/I |
20,000 |
14,774,942 |
2.25 |
% |
|
| BDSX |
Biodesix Inc |
Director |
– • • |
2021-11-17 |
4 |
B |
$6.51 |
$130,104 |
I/I |
20,000 |
6,055,953 |
2.25 |
- |
|
| BDSX |
Biodesix Inc |
Director |
– • • |
2021-11-22 |
4 |
B |
$6.34 |
$126,756 |
I/I |
20,000 |
6,164,314 |
2.25 |
- |
|
| AXDX |
Accelr8 Technology Corp |
Director |
– • • |
2021-12-16 |
4 |
B |
$4.60 |
$92,000 |
I/I |
20,000 |
18,321,963 |
2.25 |
% |
|
| BDSX |
Biodesix Inc |
|
• • • |
2022-12-15 |
4 |
B |
$1.65 |
$32,952 |
I/I |
20,000 |
20,329,189 |
0.01 |
- |
|
| VMSI |
Ventana Medical Systems I... |
Director |
– • – |
2006-12-19 |
4 |
D |
$42.30 |
$853,699 |
D/D |
(20,182) |
1,224,193 |
0 |
- |
|
| VMSI |
Ventana Medical Systems I... |
Director |
– • – |
2006-12-19 |
4/A |
D |
$42.30 |
$853,699 |
D/D |
(20,182) |
2,312,168 |
0 |
- |
|
| SLNO |
Soleno Therapeutics Inc |
10% Owner |
– – • |
2021-01-20 |
4 |
S |
$2.10 |
$42,484 |
I/I |
(20,277) |
10,954,255 |
0 |
% |
|
| YTEN |
Yield10 Bioscience Inc |
|
• • • |
2022-10-21 |
4 |
S |
$3.09 |
$62,844 |
I/I |
(20,338) |
779,853 |
0 |
% |
|
| SLNO |
Soleno Therapeutics Inc |
10% Owner |
– – • |
2019-04-17 |
4 |
B |
$1.94 |
$40,327 |
I/I |
20,769 |
751,931 |
1.5 |
- |
|
| QDEL |
QuidelOrtho Corporation |
Director |
– • – |
2011-08-05 |
4 |
B |
$14.07 |
$293,639 |
D/D |
20,865 |
3,168,153 |
2.39 |
- |
|
| QDEL |
QuidelOrtho Corporation |
Director |
– • – |
2009-05-28 |
4 |
B |
$12.14 |
$259,082 |
I/I |
21,334 |
225,835 |
2.1 |
- |
|
| ONCT |
Oncternal Therapeutics In... |
10% Owner |
– – • |
2010-12-14 |
4 |
S |
$2.58 |
$55,470 |
I/I |
(21,500) |
21,500 |
0 |
- |
|
| SLNO |
Soleno Therapeutics Inc |
10% Owner |
– – • |
2019-04-15 |
4 |
B |
$1.99 |
$43,675 |
I/I |
21,953 |
720,600 |
1.5 |
- |
|
| AXDX |
Accelr8 Technology Corp |
Director |
– • • |
2015-03-09 |
4 |
B |
$17.18 |
$387,993 |
I/I |
22,584 |
10,757,173 |
2.25 |
- |
|
634 Records found
|
|
Page 14 of 26 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
